HDAC9 and medullary thyroid gland carcinoma: In addition, the use of HDAC inhibitors to treat TC has been well described, although they failed to trigger a major response against PTC, ATC, and MTC in clinical trials, HDAC inhibitors produced encouraging results in PTC, ATC, and MTC cell lines (44–46).